Understand the source comparison
Comparison Table: SS-LUP-332 for ERR Agonist vs Other Metabolic Research Compounds
Researchers selecting compounds for metabolic studies need to understand how SS-LUP-332 for ERR agonist activity compares to alternative research tools across mechanism, application, and practical handling considerations. SS-LUP-332 (ERR agonist) Enhances ERR
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers selecting compounds for metabolic studies need to understand how SS-LUP-332 for ERR agonist activity compares to alternative research tools across mechanism, application, and practical handling considerations.
- SS-LUP-332 (ERR agonist)
- Enhances ERR transcriptional activity; upregulates mitochondrial biogenesis and oxidative metabolism genes
- Skeletal muscle, cardiac muscle, liver, brown adipose tissue
- Mitochondrial function, oxidative capacity, energy expenditure, exercise adaptation
- DMSO reconstitution; −20°C storage; hydrophobic
- Limited published pharmacokinetic data; bioavailability varies by route
- Best choice for transcriptional studies of oxidative metabolism independent of energy stress or appetite pathways
- GLP-1 agonists (Semaglutide, Tirzepatide)
- Incretin receptor activation; slows gastric emptying; CNS-mediated appetite suppression
- Pancreas, GI tract, hypothalamus
- Appetite regulation, glucose homeostasis, body weight models
- Bacteriostatic water; 2–8°C storage; hydrophilic peptide
- Mechanism irrelevant for mitochondrial studies; requires central pathway integrity
- Use for appetite and incretin signaling research. Not for cellular oxidative metabolism studies
- AMPK activators (Metformin, AICAR)
- Senses cellular energy stress (AMP:ATP ratio); activates PGC-1α via phosphorylation
- Ubiquitous. All tissues with AMPK expression
- Energy stress response, glucose uptake, autophagy, metabolic adaptation to caloric restriction
- Water-soluble; stable at room temperature
- Requires energy depletion to activate; off-target effects at high doses
- Upstream of ERR pathway. Use when studying energy stress sensing rather than basal oxidative capacity
- PPAR agonists (Fenofibrate, Pioglitazone)
- Nuclear receptor activation; regulates lipid transport, storage, and insulin sensitivity
- Liver (PPARα), adipose tissue (PPARγ)
- Lipid metabolism, insulin sensitization, adipocyte differentiation
- DMSO or ethanol; −20°C storage
- Focuses on lipid storage/transport. Not oxidative catabolism
- Choose for lipid handling studies; ERR agonists superior for oxidative metabolism and mitochondrial biogenesis
- Mitochondrial uncouplers (DNP)
- Disrupts proton gradient; forces heat production instead of ATP synthesis
- All tissues with mitochondria
- Thermogenesis, extreme energy expenditure models
- DMSO; −20°C storage; highly lipophilic
- Narrow therapeutic window; toxicity risk; non-specific mechanism
- Dangerous for routine research; ERR agonists provide targeted metabolic activation without uncoupler toxicity